Klinkhamer Group | conferences & events
 
Free Live WC11 webinars on 
3Rs in COVID-19 research
25 and 26 August 2020 | 3 PM CET
 
 
On 25 and 26 August 2020 at 3 PM CET, WC11 will organize two 1.5 hour webinars on 3Rs in COVID-19 research. On both days, several excellent presentations will highlight innovative model systems to study COVID-19, and will also discuss new strategies for the development of vaccines, therapeutics and diagnostics and much more!
 
Is there a role for the 3RS in COVID-19 research?
 
In the past few weeks we have asked several people to answer the question: "Is there a role for the 3Rs in COVID-19 research?". Every week we will send you the answers we received from scientists all over the world.
 
Troy Seidle
Vice-President Research and Toxicology of the Humane Society International (Canada)
 
“Existing non-animal approaches can already help us understand the biology, behaviour and potential countermeasures to COVID-19, including human lung tissue cultures, organ-on-a-chip technologies, other cell-based models and computational tools. These methods don’t just spare animals. They are in general also more human-predictive and both time- and cost-efficient, maximizing the quality and relevance of the information we can gather. We are at a tipping point in bioscience research, where the “gold standard" is shifting from rodent to human biology, and non-animal technologies that can better simulate and predict human outcomes in the real world. Stakeholders need to work together to accelerate this shift, rallying scientific support for the necessary policy and financial instruments to establish animal-free research and safety assessment as a priority going forward. Especially now, in the context of a pandemic, we need to support the scientific community in developing and deploying new and better instruments suited to produce relevant results more quickly and reliably to save human lives.”
Thomas Hartung
Director Center for Alternatives to Animal testing, Johns Hopkins University Bloomberg School of Public Health (United States of America)
 
“COVID-19 urges us to have make drugs and vaccines available in months or few years, processes which typically take a decade. 3Rs methods are one accelerator and COVID-19 might be a door-opener for their broader use in the future.”
Benjamin Smith
Director, Innovations in Food and Chemical Safety Programme, Agency for Science, Technology and Research (Singapore)
 
“The short answer is yes. There is definitely a place for the 3Rs in COVID-19 research. The principle of the 3Rs needs to be carefully considered for all research areas. In fact, there is already a lot of work under way in the field of vaccines looking at non-animal alternatives, including for vaccine production. I also think that in vitro models, such as lung epithelial models and organoids that allow viral replication, can help us understand mechanisms of pathogenesis and allow us to more easily study interspecies differences and that such models will become more popular for virology research in the future. That being said, especially under pandemic conditions whereby we are rushing to develop vaccines, we have to acknowledge that animal models are still important, and although many of us support the eventual end goal of moving fully away from animal testing, for now we need to use every tool in our tool kit to battle COVID-19”.
 
Register now for free!
 
It is now possible to register for this important and interesting webinar series by clicking the button below.
 
Click here
 
 
 
11th World Congress on Alternatives and Animal Use in the Life Sciences
E. info@wc11maastricht.org
T. +31 (0)43 362 70 08
 
 
This email was sent to
You received this email because you are registered to the WC11 mailing list.
 
 
 
© 2020 Klinkhamer Group | conferences & events